Clinical Trial Update: Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection [NA]

View source ↗

Summary

This clinical trial update assesses whether 2% cyclosporine eye drops can prevent corneal graft rejection; the status and results are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Graft Rejection

Drugs mentioned

• Cyclosporine ophthalmic solution (2%) (cyclosporine)

Snippet

Sponsor: Aravind Eye Care System | Conditions: Corneal Graft Rejection | NA | Status: UNKNOWN